RDoC-CBT: Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents

Sponsor
Yale University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT01965184
Collaborator
National Institute of Mental Health (NIMH) (NIH)
101
1
2
108.9
0.9

Study Details

Study Description

Brief Summary

This is a randomized controlled study of cognitive-behavioral therapy (CBT) for disruptive behavior such as irritability, anger and aggression in children and adolescents. CBT will be compared to Supportive Psychotherapy (SPT) and participants of this study will be randomly assigned (like the flip of a coin) to receive CBT or SPT. Participants will be also asked to complete functional magnetic resonance imaging (fMRI) and electrophysiological (EEG) tasks (recordings/images of brain activity) before and after treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive-Behavioral Therapy for Anger and Aggression
  • Behavioral: Supportive Psychotherapy (SPT)
N/A

Detailed Description

Cognitive-behavioral therapy (CBT) is a behavioral intervention that consists of 12 weekly sessions. During CBT children are taught various skills for coping with frustration and parents are taught various strategies for managing situations that can be anger provoking for their child. This study is conducted to examine whether reduction of behavioral problems including anger outbursts, irritability, aggression and noncompliance after CBT may be paralleled by changes in areas of the brain responsible for emotion regulation and social perception.

Study Design

Study Type:
Interventional
Actual Enrollment :
101 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Using CBT to Examine Circuitry of Frustrative Non-reward in Aggressive Children
Actual Study Start Date :
Nov 14, 2013
Actual Primary Completion Date :
Aug 3, 2018
Anticipated Study Completion Date :
Dec 12, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive-Behavioral Therapy for Anger and Aggressive Behavior

CBT is a behavioral intervention that consists of 12 weekly sessions. During CBT children are taught various skills for coping with frustration and parents are taught various strategies for managing situations that can be anger provoking for their child.

Behavioral: Cognitive-Behavioral Therapy for Anger and Aggression

Active Comparator: Supportive Psychotherapy (SPT)

SPT consists of 12 sessions that are focused on discussing peer relationships and family functioning with a goal of enhancing subjective well-being

Behavioral: Supportive Psychotherapy (SPT)

Outcome Measures

Primary Outcome Measures

  1. Modified Overt Aggression Scale [basline (week 0)]

    Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.

  2. Modified Overt Aggression Scale [midpoint (week 6)]

    Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.

  3. Modified Overt Aggression Scale [endpoint (week 12)]

    Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.

  4. Modified Overt Aggression Scale [follow up (3 months)]

    Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.

  5. The Clinical Global Impression - Improvement Score [basline (week 0)]

    The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response.

  6. The Clinical Global Impression - Improvement Score [midpoint (week 6)]

    The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response.

  7. The Clinical Global Impression - Improvement Score [endpoint (week 12)]

    The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response.

  8. The Clinical Global Impression - Improvement Score [follow up (3 months)]

    The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response.

Secondary Outcome Measures

  1. The Child Behavior Checklist [basline (week 0)]

    The Child Behavior Checklist is a parent rating of child psychopathology that has two factor-analytically derived scales of disruptive behavior. Child Behavior Checklist Aggressive Behavior Scale consists of 18 items, rated as 0, 1 or 2, with a scale raw score range from 0 (minimum) to 36 (maximum) with higher scores reflecting worse outcome. Raw scores are also converted to T-scores with possible range from 0 to 100 with higher scores reflecting worse outcomes and T-scores of 65 and higher reflecting clinically significant range.

  2. The Child Behavior Checklist [midpoint (week 6)]

    The Child Behavior Checklist is a parent rating of child psychopathology that has two factor-analytically derived scales of disruptive behavior. Child Behavior Checklist Aggressive Behavior Scale consists of 18 items, rated as 0, 1 or 2, with a scale raw score range from 0 (minimum) to 36 (maximum) with higher scores reflecting worse outcome. Raw scores are also converted to T-scores with possible range from 0 to 100 with higher scores reflecting worse outcomes and T-scores of 65 and higher reflecting clinically significant range.

  3. The Child Behavior Checklist [endpoint (week 12)]

    The Child Behavior Checklist is a parent rating of child psychopathology that has two factor-analytically derived scales of disruptive behavior. Child Behavior Checklist Aggressive Behavior Scale consists of 18 items, rated as 0, 1 or 2, with a scale raw score range from 0 (minimum) to 36 (maximum) with higher scores reflecting worse outcome. Raw scores are also converted to T-scores with possible range from 0 to 100 with higher scores reflecting worse outcomes and T-scores of 65 and higher reflecting clinically significant range.

  4. The Child Behavior Checklist [follow up (3 months)]

    The Child Behavior Checklist is a parent rating of child psychopathology that has two factor-analytically derived scales of disruptive behavior. Child Behavior Checklist Aggressive Behavior Scale consists of 18 items, rated as 0, 1 or 2, with a scale raw score range from 0 (minimum) to 36 (maximum) with higher scores reflecting worse outcome. Raw scores are also converted to T-scores with possible range from 0 to 100 with higher scores reflecting worse outcomes and T-scores of 65 and higher reflecting clinically significant range.

Other Outcome Measures

  1. functional magnetic resonance imaging (fMRI) [baseline (week 0)]

    fMRI scanning with tasks of emotion regulation and social perception

  2. Electroencephalography (EEG) [baseline (week 0)]

    EEG recordings will be collected as participants perform tasks of emotion regulation and social perception

  3. functional magnetic resonance imaging (fMRI) [endpoint (week 12)]

    fMRI scanning with tasks of emotion regulation and social perception

  4. Electroencephalography (EEG) [endpoint (week 12)]

    EEG recordings will be collected as participants perform tasks of emotion regulation and social perception

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Boys and girls, 8 to 16 years of age.

  2. T-Score > 65 on the parent-rated Aggressive Behavior Scale of the Child Behavior Checklist (CBCL).

  3. Unmedicated or on stable medication for aggression, ADHD, anxiety, or depression for at least 6 weeks, with no planned changes for duration of study.

  4. Children can speak English sufficiently enough to participate in CBT and study assessments.

  5. Children should have 1) no metal medical implants, 2) a body weight of less than 250 lbs. and 3) no claustrophobia. [These are necessitated by the safety requirements of the fMRI.]

  6. Children should be able to meet fMRI data quality requirements at baseline [to enable pre- to post-treatment comparison.]

  7. Families can commute to the Yale Child Study Center in New Haven, CT for weekly visits.

Exclusion Criteria:
  1. IQ below 85.

  2. Children across various DSM diagnoses will be eligible for participation. However, significant levels of psychopathology that require immediate clinical attention such as severe depression or psychosis will be exclusionary because it will require alternative treatments.

  3. Significant medical condition such as heart disease, hypertension, liver or renal failure, pulmonary disease, seizure disorder, brain injury based on medical history which can interfere with participation in the study.

  4. Concurrent psychotherapy can continue, but CBT for aggression is exclusionary. Subjects will be asked not to initiate any new child psychotherapy during the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yale University New Haven Connecticut United States 06520

Sponsors and Collaborators

  • Yale University
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Denis G. Sukhodolsky, Ph.D., Yale University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Yale University
ClinicalTrials.gov Identifier:
NCT01965184
Other Study ID Numbers:
  • 0102012121-C
  • R01MH101514
First Posted:
Oct 18, 2013
Last Update Posted:
Jan 27, 2022
Last Verified:
Jan 1, 2022

Study Results

No Results Posted as of Jan 27, 2022